keyword
https://read.qxmd.com/read/38629811/ketamine-induces-multiple-individually-distinct-whole-brain-functional-connectivity-signatures
#21
JOURNAL ARTICLE
Flora Moujaes, Jie Lisa Ji, Masih Rahmati, Joshua B Burt, Charles Schleifer, Brendan D Adkinson, Aleksandar Savic, Nicole Santamauro, Zailyn Tamayo, Caroline Diehl, Antonija Kolobaric, Morgan Flynn, Nathalie Rieser, Clara Fonteneau, Terry Camarro, Junqian Xu, Youngsun Cho, Grega Repovs, Sarah K Fineberg, Peter T Morgan, Erich Seifritz, Franz X Vollenweider, John H Krystal, John D Murray, Katrin H Preller, Alan Anticevic
BACKGROUND: Ketamine has emerged as one of the most promising therapies for treatment-resistant depression. However, inter-individual variability in response to ketamine is still not well understood and it is unclear how ketamine's molecular mechanisms connect to its neural and behavioral effects. METHODS: We conducted a single-blind placebo-controlled study, with participants blinded to their treatment condition. 40 healthy participants received acute ketamine (initial bolus 0...
April 17, 2024: ELife
https://read.qxmd.com/read/38629735/overcoming-the-blood-brain-tumor-barrier-with-docetaxel-loaded-mesoporous-silica-nanoparticles-for-treatment-of-temozolomide-resistant-glioblastoma
#22
JOURNAL ARTICLE
Tsung-I Hsu, Yi-Ping Chen, Rong-Lin Zhang, Zih-An Chen, Cheng-Hsun Wu, Wen-Chang Chang, Chung-Yuan Mou, Hardy Wai-Hong Chan, Si-Han Wu
While temozolomide (TMZ) has been a cornerstone in the treatment of newly diagnosed glioblastoma (GBM), a significant challenge has been the emergence of resistance to TMZ, which compromises its clinical benefits. Additionally, the nonspecificity of TMZ can lead to detrimental side effects. Although TMZ is capable of penetrating the blood-brain barrier (BBB), our research addresses the need for targeted therapy to circumvent resistance mechanisms and reduce off-target effects. This study introduces the use of PEGylated mesoporous silica nanoparticles (MSN) with octyl group modifications (C8-MSN) as a nanocarrier system for the delivery of docetaxel (DTX), providing a novel approach for treating TMZ-resistant GBM...
April 17, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38629661/a-qualitative-exploration-of-oncology-clinician-s-needs-for-pgt-m-discussions-in-clinical-practice
#23
JOURNAL ARTICLE
Davia A Schioppo, Jessica P H Greenwood, Kristen A Miller, Hetal S Vig
Purpose: Oncology clinicians are appropriately positioned to facilitate discussions of assisted reproductive technologies including preimplantation genetic testing for monogenic disease (PGT-M), in the context of cancer treatment or surveillance. Yet, reproductive services, including PGT-M, remain one of the least implemented services in oncology. No studies to date have explored which practice resources the clinicians need to increase knowledge of PGT-M. The objective of this study was to explore the specific needs of oncology clinicians to help maximize the reproductive potential of young adult patients with hereditary cancers...
April 17, 2024: Journal of Adolescent and Young Adult Oncology
https://read.qxmd.com/read/38629634/pain-during-primary-molar-local-anaesthesia-with-sleeperone5-computerized-device-versus-conventional-syringe-a-randomized-split-mouth-crossover-controlled-trial
#24
JOURNAL ARTICLE
Michèle Muller-Bolla, Elody Aïem, Clara Joseph, Tiphaine Davit-Béal, Thomas Marquillier, Emmanuelle Esclassan, Caroline Delfosse, Serena Lopez, Ana Miriam Velly
BACKGROUND: Because of controversial results from clinical studies comparing different dental local anesthesia methods in children, the primary objective of this randomized, split-mouth, crossover, controlled trial was to compare pain intensity during local anaesthesia (LA) performed with a computer-controlled LA delivery system (C-CLADS) versus a conventional syringe (CONV). Secondary objectives included comparisons during dental treatment. METHODS: Participants (4-8 years) with tooth pair requiring similar treatment were recruited from five French hospitals...
April 17, 2024: International Journal of Paediatric Dentistry
https://read.qxmd.com/read/38629378/guanidinium-based-integrated-peptide-dendrimers-pioneer-nanocarrier-in-cancer-therapy
#25
JOURNAL ARTICLE
Dilpreet Singh, Lalu Muhammad Irham, Amrinder Singh, Balak Das Kurmi
The landscape of cancer therapy has witnessed a paradigm shift with the emergence of innovative delivery systems, and Guanidinium-based Peptide Dendrimers have emerged as a vanguard in this transformative journey. With their unique molecular architecture and intrinsic biocompatibility, these dendrimers offer a promising avenue for the targeted delivery of therapeutic cargo in cancer treatment. This comprehensive review delves into the intricate world of Guanidinium- based Peptide Dendrimers, unraveling their structural intricacies, mechanisms of action, and advancements that have propelled them from laboratory curiosities to potential clinical champions...
April 16, 2024: Protein and Peptide Letters
https://read.qxmd.com/read/38629376/a-comprehensive-review-on-glp-1-signaling-pathways-in-the-management-of-diabetes-mellitus-focus-on-the-potential-role-of-glp-1-receptors-agonists-and-selenium-among-various-organ-systems
#26
JOURNAL ARTICLE
Ghinwa Barakat, Ghaith Assi, Hussein Khalil, Sami El Khatib
Diabetes Mellitus develops when the body becomes unable to fuel its cells with glucose, which results in the accumulation of sugar excess in the bloodstream. Because it has diverse pathophysiological impacts on the body, diabetes mellitus represents a significant issue of concern in an attempt to find suitable treatment modalities and medications for afflicted diabetic patients. Glucagon-like peptide 1 (GLP-1) plays a pivotal role in the incretin effect, emerging as a prospective treatment for diabetes mellitus and a promising means of regenerating pancreatic cells, whether directly or through its receptor agonists...
April 16, 2024: Current Diabetes Reviews
https://read.qxmd.com/read/38629370/unlocking-the-potential-of-induced-pluripotent-stem-cells-in-revolutionizing-cancer-therapy
#27
JOURNAL ARTICLE
Amrita Mondal, Ankita Talukdar, Rizwanul Haque
Induced Pluripotent Stem Cells (iPSCs) are among the top versatile implements of biomedical research. Stem cell science has made strides over the past few years, emerging as a new opportunity to treat cancer, and many such continuous initiatives have been made into clinical trials. As the global mortality rate is too high despite the effectiveness of prevalent cancer therapies, this review explores the potential of iPSC in different aspects of cancer-related areas. The preparation of iPSCs, including their derivation from cancer stem cells, was covered after establishing the intricacy of current cancer treatments...
April 15, 2024: Current Stem Cell Research & Therapy
https://read.qxmd.com/read/38629366/review-on-emerging-therapeutic-strategies-for-managing-cardiovascular-disease
#28
JOURNAL ARTICLE
Minal Narkhede, Avinash Pardeshi, Rahul Bhagat, Gajanan Dharme
Cardiovascular disease (CVD) remains a foremost global health concern, necessitating ongoing exploration of innovative therapeutic strategies. This review surveys the latest developments in cardiovascular therapeutics, offering a comprehensive overview of emerging approaches poised to transform disease management. The examination begins by elucidating the current epidemiological landscape of CVD and the economic challenges it poses to healthcare systems. It proceeds to scrutinize the limitations of traditional therapies, emphasizing the need for progressive interventions...
April 16, 2024: Current Cardiology Reviews
https://read.qxmd.com/read/38629297/dissonance-in-the-face-of-alzheimer-s-disease-breakthroughs-clinician-and-lay-stakeholder-acceptance-concerns-and-willingness-to-pay-for-emerging-disease-modifying-therapies
#29
JOURNAL ARTICLE
Irina Kinchin, Sharon Walsh, Rachel Dinh, Margaret Kapuwa, Sean P Kennelly, Ann-Marie Miller, Ann Nolan, Sean O'Dowd, Laura O'Philbin, Suzanne Timmons, Iracema Leroi
BACKGROUND: Introducing new disease-modifying therapies (DMTs) for Alzheimer's disease demands a fundamental shift in diagnosis and care for most health systems around the world. Understanding the views of health professionals, potential patients, care partners and taxpayers is crucial for service planning and expectation management about these new therapies. AIMS: To investigate the public's and professionals' perspectives regarding (1) acceptability of new DMTs for Alzheimer's disease; (2) perceptions of risk/benefits; (3) the public's willingness to pay (WTP)...
April 17, 2024: British Journal of Psychiatry
https://read.qxmd.com/read/38629024/assessing-the-impact-of-the-covid-19-pandemic-on-maternal-and-child-health-services-a-comprehensive-analysis-of-government-initiatives-in-northern-india
#30
JOURNAL ARTICLE
Garima Jain, Ram Komal Prasad Prajapati, Vikram Bisen
BACKGROUND: The coronavirus disease (COVID-19) pandemic has significantly impacted healthcare services globally, with particular challenges observed in maternal and child health (MCH) care. This study aimed to assess the impact of the pandemic on MCH services in northern India, focusing on key government programs. METHODS: Data were collected from four major MCH programs in India: Janani Suraksha Yojana (JSY), Janani Shishu Suraksha Karyakram (JSSK), Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA), and the Universal Immunization Program (UIP)...
March 2024: Curēus
https://read.qxmd.com/read/38628989/a-rare-case-of-a-patient-being-alert-and-communicative-despite-severe-hypothermia
#31
Emile Jeunesse, Patrick O'Malley, Nick Petrus, Chelsea McCoy
Hypothermia is defined as a significant drop in core body temperature below 35°C (95°F). It is traditionally staged as mild, moderate, severe, and profound at temperatures of 35°C to 32°C (95°F to 89.6°F), 32°C to 28°C (89.6°F to 82.4°F), <28°C (<82.4°F), and <24°C (75.2°F), respectively. It can also be classified into the same stages by clinical presentations. We present a patient that fits into two different stages based on core body temperature and clinical presentation...
March 2024: Curēus
https://read.qxmd.com/read/38628972/non-invasive-suppression-of-the-human-nucleus-accumbens-nac-with-transcranial-focused-ultrasound-tfus-modulates-the-reward-network-a-pilot-study
#32
JOURNAL ARTICLE
Xiaolong Peng, Dillon J Connolly, Falon Sutton, John Robinson, Brenna Baker-Vogel, Edward B Short, Bashar W Badran
BACKGROUND: The nucleus accumbens (NAc) is a key node of the brain reward circuit driving reward-related behavior. Dysregulation of NAc has been demonstrated to contribute to pathological markers of addiction in substance use disorder (SUD) making it a potential therapeutic target for brain stimulation. Transcranial focused ultrasound (tFUS) is an emerging non-invasive brain stimulation approach that can modulate deep brain regions with a high spatial resolution. However, there is currently no evidence showing how the brain activity of NAc and brain functional connectivity within the reward network neuromodulated by tFUS on the NAc...
2024: Frontiers in Human Neuroscience
https://read.qxmd.com/read/38628929/a-case-of-successful-hybrid-treatment-of-dual-arterial-bypass-using-indocyanine-green-fluorescence-angiography-and-endovascular-treatment-for-recurrent-superior-mesenteric-artery-aneurysm
#33
Keisuke Yoshida, Yujiro Miura, Naoki Edo, Atsuyuki Mitsuishi, Tomohiro Matsumoto, Hiroyuki Kitagawa
A 54-year-old woman with a mycotic superior mesenteric artery (SMA) aneurysm underwent emergent aneurysm resection with a great saphenous vein bypass. Follow-up computed tomography revealed a rapidly growing recurrent SMA aneurysm at the stump. Under the diagnosis of recurrent pseudoaneurysm of SMA with a fragile stump, we performed an open dual arterial bypass using indocyanine green fluorescence angiography and endovascular coil embolization. Subsequently, the patient's recurrent mycotic SMA aneurysm was successfully managed without mesenteric ischemic complications...
March 25, 2024: Annals of Vascular Diseases
https://read.qxmd.com/read/38628772/efficacy-and-safety-of-ibrexafungerp-in-the-treatment-of-vulvovaginal-candidiasis-a-meta-analysis-of-randomized-controlled-trials
#34
JOURNAL ARTICLE
Rong He, Fei Lin, Bin Yu, Ling Huang
BACKGROUND: This study aims to evaluate the efficacy and safety associated with ibrexafungerp in the treatment of vulvovaginal candidiasis infection patients. METHODS: We conducted a comprehensive search of the PubMed, Embase, Cochrane Library, and Clinical Trials databases up to December 25, 2022. The primary outcomes were clinical cure rate and mycological eradication rate, whereas the secondary outcomes were the risk of an adverse events. RESULTS: In total of four studies encompassing 880 patients diagnosed with vulvovaginal candidiasis (VVC) were included in the analysis...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38628770/-leucaena-leucocephala-succinate-based-polyelectrolyte-complexes-for-colon-delivery-of-synbiotic-in-management-of-inflammatory-bowel-disease
#35
JOURNAL ARTICLE
Gaganpreet Kaur, Aman Kumar, Samridhi Kurl, Neeraj Mittal, Deepinder Singh Malik, Pallavi Bassi, Tanveer Singh, Azmat Ali Khan, Amer M Alanazi, Gurpreet Kaur
Polyelectrolyte complexes (PECs) formed by the interaction between oppositely charged polymers have emerged as promising carriers for accomplishing colon-specific release. In this study, we have explored the potential of polyelectrolyte complexes between a succinate derivative of Leucaena leucocephala galactomannan and cationic guar gum for colon delivery of synbiotic. The PECs were prepared using a polyelectrolyte complexation method and characterized. The PECs exhibited excellent stability, with high encapsulation efficiency for both probiotics (95...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38628722/identification-of-cnksr1-as-a-biomarker-for-cold-tumor-microenvironment-in-lung-adenocarcinoma-an-integrative-analysis-based-on-a-novel-workflow
#36
JOURNAL ARTICLE
Qidong Cai, Mou Peng
BACKGROUND: Therapies targeting PD1/PD-L1 pathway have revolutionized the treatment of lung cancer. However, anti-PD1/PD-L1 therapies have proven beneficial for only a select group of lung adenocarcinoma (LUAD) patients and generally do not work for immuno-cold tumors characterized by a lack of immune cell infiltration. Identifying novel biomarkers is vital to broad therapeutic options for LUAD patients with no response to anti-PD1/PD-L1 immunotherapies. METHODS: Our study has developed a novel strategy to identify a promising biomarker that addresses the limitations of anti-PD1/PD-L1 immunotherapy in treating immunological cold tumors...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38628701/a-bibliometric-analysis-of-cerebral-palsy-from-2003-to-2022
#37
Yue Hu, Yadan Zheng, Yue Yang, Wenfeng Fang, Maomao Huang, Dan Li, Zhangyu Xu, Fangyuan Xu, Jianxiong Wang
PURPOSE: This bibliometric study explores cerebral palsy (CP) research from 2003 to 2022 to reveal the topic hotspots and collaborations. METHODS: We retrieved studies on CP from the Web of Science Core Collection from 2003 to 2022 and then used CiteSpace and Bibliometrix to perform a bibliometric analysis and attain knowledge mapping, including publication outputs, funding, journals, authors, institutions, countries/territories, keywords, collaborative relationships, and topic hotspots...
2024: Frontiers in Neurology
https://read.qxmd.com/read/38628674/management-of-cardiac-emergencies-in-women-a-clinical-consensus-statement-of-the-association-for-acute-cardiovascular-care-acvc-the-european-association-of-percutaneous-cardiovascular-interventions-eapci-the-heart-failure-association-hfa-and-the-european-heart
#38
REVIEW
Antonia Sambola, Sigrun Halvorsen, David Adlam, Christian Hassager, Susanna Price, Giuseppe Rosano, Francois Schiele, Lene Holmvang, Marta de Riva, Amina Rakisheva, Patrick Sulzgruber, Eva Swahn
Cardiac emergencies in women, such as acute coronary syndromes, acute heart failure, and cardiac arrest, are associated with a high risk of adverse outcomes and mortality. Although women historically have been significantly underrepresented in clinical studies of these diseases, the guideline-recommended treatment for these emergencies is generally the same for both sexes. Still, women are less likely to receive evidence-based treatment compared to men. Furthermore, specific diseases affecting predominantly or exclusively women, such as spontaneous coronary dissection, myocardial infarction with non-obstructive coronary arteries, takotsubo cardiomyopathy, and peripartum cardiomyopathy, require specialized attention in terms of both diagnosis and management...
March 2024: Eur Heart J Open
https://read.qxmd.com/read/38628673/anemia-in-patients-receiving-anticancer-treatments-focus-on-novel-therapeutic-approaches
#39
REVIEW
Claudia Bozzini, Fabiana Busti, Giacomo Marchi, Alice Vianello, Claudio Cerchione, Giovanni Martinelli, Domenico Girelli
Anemia is common in cancer patients and impacts on quality of life and prognosis. It is typically multifactorial, often involving different pathophysiological mechanisms, making treatment a difficult task. In patients undergoing active anticancer treatments like chemotherapy, decreased red blood cell (RBC) production due to myelosuppression generally predominates, but absolute or functional iron deficiency frequently coexists. Current treatments for chemotherapy-related anemia include blood transfusions, erythropoiesis-stimulating agents, and iron supplementation...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38628665/the-radiation-therapy-technology-evidence-matrix-a-framework-to-visualize-evidence-development-for-innovations-in-radiation-therapy
#40
JOURNAL ARTICLE
Sarah Edwards, Marco Luzzara, Veronica Dell'Acqua, John Christodouleas
Clinical evidence is crucial in enabling the judicious adoption of technological innovations in radiation therapy (RT). Pharmaceutical evidence development frameworks are not useful for understanding how technical advances are maturing. In this paper, we introduce a new framework, the Radiation Therapy Technology Evidence Matrix (rtTEM), that helps visualize how the clinical evidence supporting new technologies is developing. The matrix is a unique 2D model based on the R-IDEAL clinical evaluation framework...
2024: Frontiers in Oncology
keyword
keyword
170206
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.